Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001415889-24-024044

Director bought 666,665 shares at $18.00 ($11,999,970)

  • Director acquired 1,638,236 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

HEALY JAMES · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-27 Conversion : show line 1 in the form +1,638,236 1,638,236 I
2024-09-27 Purchase : show line 2 in the form +588,888 $18.00 $10,599,984 2,227,124 I
2024-09-27 Purchase : show line 3 in the form +11,113 $18.00 $200,034 11,113 I
2024-09-27 Purchase : show line 4 in the form +18,353 $18.00 $330,354 18,353 I
2024-09-27 Purchase : show line 5 in the form +21,814 $18.00 $392,652 21,814 I
2024-09-27 Purchase : show line 6 in the form +26,497 $18.00 $476,946 26,497 I
Open-market purchases · 666,665 sh · avg $18.00 · $11,999,970

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-09-25 Grant or award : show line 7 in the form Stock Option (Right to Buy) +15,000 15,000 D
2024-09-27 Conversion : show line 8 in the form Series D Preferred Stock −7,310,796 0 I
Loading xslF345X05/form4-09272024_080939.xml…